Astrana Health (ASTH) Enterprise Value (2010 - 2026)

Astrana Health has reported Enterprise Value for 17 years, with the latest figure at -$463.5 million in Q1 2026.

• Quarterly Enterprise Value rose 6.12% year-over-year to -$463.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$463.5 million (up 6.12% YoY) and the FY2025 annual result came in at -$415.5 million, up 15.79% from the prior year.
• Enterprise Value fell to -$463.5 million in Q1 2026 per ASTH's latest filing, from -$415.5 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$177.1 million in Q3 2022 and troughed at -$575.7 million in Q2 2025.
• A 5-year average of -$396.8 million and a median of -$449.9 million in 2025 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value climbed 27.26% in 2022, then sank 113.43% in 2024.
• Over 5 years, Enterprise Value stood at -$279.4 million in 2022, then plunged by 79.77% to -$502.2 million in 2023, then increased by 1.75% to -$493.4 million in 2024, then increased by 15.79% to -$415.5 million in 2025, then dropped by 11.55% to -$463.5 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$463.5 million, -$415.5 million, and -$449.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.